Location via proxy:
[ UP ]
[Report a bug]
[Manage cookies]
No cookies
No scripts
No ads
No referrer
Show this form
Factors associated with suboptimal response to monoclonal antibodies in severe asthma
Allergy
.
2023 Aug;78(8):2305-2310.
doi: 10.1111/all.15693.
Epub 2023 Mar 18.
Authors
Luis Pérez de Llano
1
,
Nuria Marina Malanda
2
,
Isabel Urrutia
3
,
Eva Martínez-Moragón
4
,
José Antonio Gullón-Blanco
5
,
Rocío Díaz-Campos
6
,
Mariana Muñoz Esquerre
7
,
Alicia Habernau Mena
8
,
Borja G Cosío
9
,
Carolina Cisneros
10
,
Francisco Javier Lázaro Polo
11
,
Daniel Laorden
12
,
David Dacal Rivas
1
Affiliations
1
Pneumology Service, Lucus Augusti University Hospital, EOXI Lugo, Cervo e Monforte, Lugo, Spain.
2
Pneumology Service, Cruces University Hospital, Barakaldo, Spain.
3
Pneumology Service, Galdakao-Usansolo University Hospital, Galdakao, Spain.
4
Pneumology Service, Doctor Peset University Hospital, Valencia, Spain.
5
Pneumology Service, San Agustín University Hospital, Avilés, Spain.
6
Pneumology Service, Doce de Octubre University Hospital, Madrid, Spain.
7
Pneumology Service, Bellvitge University Hospital, IBIDELL, Barcelona University, Barcelona, Spain.
8
Allergy Section, Internal Medicine Service, Complejo Hospitalario de Mérida, Badajoz, Spain.
9
Pneumology Service, Son Espases University Hospital, IdISBa-Ciberes, Palma de Mallorca, Spain.
10
Pneumology Service, La Princesa University Hospital, Madrid, Spain.
11
Pneumology Service, Ciudad Real University Hospital, Ciudad Real, Spain.
12
Pneumology Service, La Paz University Hospital, Madrid, Spain.
PMID:
36866939
DOI:
10.1111/all.15693
No abstract available
Publication types
Letter
MeSH terms
Anti-Asthmatic Agents* / therapeutic use
Antibodies, Monoclonal / therapeutic use
Asthma* / diagnosis
Asthma* / drug therapy
Humans
Substances
Antibodies, Monoclonal
Anti-Asthmatic Agents